OPTIMIZATION OF ANALYTICAL PARAMETERS FOR ROPINIROLE DETERMINATION – A REVIEW

Ropinirole, a selective non-ergot dopamine D2/D3 receptor agonist, is widely used for the treatment of Parkinson’s disease (PD) and Restless Legs Syndrome (RLS). Its therapeutic relevance necessitates accurate, sensitive, and reliable analytical methods for its determination in pharmaceutical formulations. This review highlights the optimization of various analytical parameters for ropinirole determination using UV spectroscopy, High-Performance Liquid Chromatography (HPLC), High-Performance Thin Layer Chromatography (HPTLC), and Ultra-High-Performance Liquid Chromatography (UHPLC). The methods differ in mobile phase composition, solvents, detection wavelengths, linearity range, Limit of Detection (LOD), and Limit of Quantization (LOQ). Comparative data from multiple references illustrate the suitability and sensitivity of each method. HPLC and UHPLC techniques demonstrated higher sensitivity and broader linearity ranges, making them more favorable for routine analysis. This review serves as a valuable resource for researchers and analysts aiming to select or optimize the most effective analytical approach for ropinirole quantification in various pharmaceutical and research applications. Keywords: Ropinirole, Parkinson’s, UV, HPLC, HPTLC, UHPLC

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2025-05-02
DOI
https://doi.org/10.5281/zenodo.15321418
Primary Topic
Parkinson's Disease Mechanisms and Treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

OPTIMIZATION OF ANALYTICAL PARAMETERS FOR ROPINIROLE DETERMINATION – A REVIEW

Zenodo (CERN European Organization for Nuclear Research)
Parkinson's Disease Mechanisms and Treatments
article

OPTIMIZATION OF ANALYTICAL PARAMETERS FOR ROPINIROLE DETERMINATION – A REVIEW

article en

Abstract

Ropinirole, a selective non-ergot dopamine D2/D3 receptor agonist, is widely used for the treatment of Parkinson’s disease (PD) and Restless Legs Syndrome (RLS). Its therapeutic relevance necessitates accurate, sensitive, and reliable analytical methods for its determination in pharmaceutical formulations. This review highlights the optimization of various analytical parameters for ropinirole determination using UV spectroscopy, High-Performance Liquid Chromatography (HPLC), High-Performance Thin Layer Chromatography (HPTLC), and Ultra-High-Performance Liquid Chromatography (UHPLC). The methods differ in mobile phase composition, solvents, detection wavelengths, linearity range, Limit of Detection (LOD), and Limit of Quantization (LOQ). Comparative data from multiple references illustrate the suitability and sensitivity of each method. HPLC and UHPLC techniques demonstrated higher sensitivity and broader linearity ranges, making them more favorable for routine analysis. This review serves as a valuable resource for researchers and analysts aiming to select or optimize the most effective analytical approach for ropinirole quantification in various pharmaceutical and research applications. Keywords: Ropinirole, Parkinson’s, UV, HPLC, HPTLC, UHPLC

Zenodo (CERN European Organization for Nuclear Research)
Openalex Percentile: Top 40%
Parkinson's Disease Mechanisms and Treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.